Ad
TIL Short Information Instil Bio Inc.
Short Information | Instil Bio Inc. (NASDAQ:TIL)
| Twenty Trading Day Totals | |
|---|---|
| Total Shorted Volume | 2,776,422 |
| Total Actual Volume | 13,176,455 |
| Short Trends | |
|---|---|
| Cover Days | 20 |
| Short Days | 0 |
| No Change Days | 0 |
| Averages | |
|---|---|
| Average Short Volume | 138,821 |
| Average Short Percentage | 19.47% |
Is there a TIL Short Squeeze or Breakout about to happen?
See the TIL Short Analysis for free Sign up or Login
Powered by Squeeze Report
TIL Twenty Trading Day's Volume to Short Volume Chart
TIL Twenty Trading Day Price Chart
TIL Short Data Results Days
| Date | Open | Close | High | Low | Total Volume | Short Volume | Short Percentage |
|---|---|---|---|---|---|---|---|
| 10-02-2024 | $60.97 | $58 | $62.41 | $58 | 158,535 | 26,126 | 16.48% |
| 10-01-2024 | $67.86 | $61.25 | $69 | $61.24 | 117,767 | 27,944 | 23.73% |
| 09-30-2024 | $67.59 | $67.32 | $69.98 | $66 | 95,437 | 24,659 | 25.84% |
| 09-27-2024 | $68.36 | $65.62 | $70.16 | $63 | 115,359 | 33,033 | 28.63% |
| 09-26-2024 | $68.95 | $68.36 | $71.97 | $67.06 | 155,586 | 32,383 | 20.81% |
| 09-25-2024 | $68.28 | $69.09 | $70.41 | $67.36 | 148,241 | 17,183 | 11.59% |
| 09-24-2024 | $65.99 | $68.28 | $72.8699 | $65.99 | 166,730 | 31,847 | 19.1% |
| 09-23-2024 | $65.86 | $67.5 | $70.05 | $63.46 | 240,329 | 40,524 | 16.86% |
| 09-20-2024 | $59.1 | $66.25 | $66.45 | $57.995 | 275,859 | 54,091 | 19.61% |
| 09-19-2024 | $66.58 | $58.75 | $70.94 | $58.53 | 287,148 | 56,289 | 19.6% |
| 09-18-2024 | $64.75 | $66.1 | $73.69 | $60.01 | 540,275 | 121,524 | 22.49% |
| 09-17-2024 | $58.02 | $64.79 | $66.425 | $51.47 | 947,918 | 226,602 | 23.91% |
| 09-16-2024 | $73 | $64.31 | $76.1279 | $58.88 | 1,842,853 | 363,895 | 19.75% |
| 09-13-2024 | $50 | $84.52 | $92 | $48.27 | 3,923,257 | 894,642 | 22.8% |
| 09-12-2024 | $29.7 | $46.46 | $59.02 | $29.5 | 1,895,344 | 388,579 | 20.5% |
| 09-11-2024 | $24.3 | $29.65 | $32.4 | $23.77 | 574,933 | 117,769 | 20.48% |
| 09-10-2024 | $21.81 | $24.58 | $24.7 | $21.4 | 460,436 | 68,981 | 14.98% |
| 09-09-2024 | $16.4 | $21.99 | $23.72 | $16.0101 | 1,144,892 | 239,236 | 20.9% |
| 09-06-2024 | $14.07 | $14.25 | $14.345 | $13.83 | 25,026 | 1,275 | 5.09% |
| 09-05-2024 | $14.75 | $14.15 | $14.75 | $13.75 | 60,530 | 9,840 | 16.26% |
News, Short Squeeze, Breakout and More Instantly...
Ad
-
2024-09-25 04:56:00 ET Investors looking for stocks that can provide dramatic gains found what they were looking for with a pair of cancer drug developers. From the end of 2023 through the closing bell on Sept. 23, shares of Summit Therapeutics and Instil Bio marched over 700% higher. ...
-
2024-09-17 04:24:00 ET September has been an exciting time for investors with their fingers on the pulse of cancer drug development. In a nutshell, it looks like the world's top-selling cancer therapy could have a serious competitor. Sales of Keytruda from Merck reached $25 billion ...
-
A look at the top 10 most actives in the United States NVIDIA Corporation (NVDA) fell 2.5% to $116.106 on volume of 42,019,244 shares Bone Biologics Corp (BBLG) rose 83.8% to $1.47 on volume of 28,279,214 shares Zentalis Pharmaceuticals Inc. (ZNTL) rose 42.7% to $4.625 on volume of 25,143,2...
Important Investor News Alert (OTC: AABB)
-
LAS VEGAS, Oct. 02, 2024 (GLOBE NEWSWIRE) -- Asia Broadband Inc. (OTC: AABB) (“AABB” or the “Company”) is pleased to announce that the development of the new next generation AABB Wallet App is nearing completion. The AABB Wallet development team, led by the Koinfold Cr...